2026年3月最新《新锐期刊分区表》数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
体验更多LetPub AI科研工具 >> | |
| 近期推荐： | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 新 聚合物期刊JPM征稿｜IF持续上升 + APC折扣 | 热 Springer Nature特刊征稿 |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Journal of Thoracic Oncology J THORAC ONCOL （此期刊被最新的JCR期刊SCIE收录） LetPub评分 9.2
50人评分
我要评分
声誉 9.9 影响力 8.6 速度 9.4 | |||||||||||||||||||||||||||||||
| 期刊ISSN | 1556-0864 | 安装APP，查看期刊最新消息
| ||||||||||||||||||||||||||||||
| E-ISSN | 1556-1380 | |||||||||||||||||||||||||||||||
| 2024-2025最新影响因子 （数据来源于搜索引擎） | 20.8 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日：22.69 | |||||||||||||||||||||||||||||||
| 2024-2025自引率 | 3.4%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||
| 五年影响因子 | 18.4 | |||||||||||||||||||||||||||||||
| JCI期刊引文指标 | 4.24 | |||||||||||||||||||||||||||||||
| h-index | 113 | |||||||||||||||||||||||||||||||
| CiteScore （ 2025年最新版） |
| |||||||||||||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||||||||||||
| 期刊官方网站 | http://www.jto.org/ | |||||||||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/JTO | |||||||||||||||||||||||||||||||
| 该期刊中国学者近期发文 - New | GSTA1 Conferred Tolerance to Osimertinib and Provided Strategies to Overcome Drug-Tolerant Persister in EGFR-Mutant Lung Adenocarcinoma Author: Zhang, Xiaoshen; Wen, Yaokai; Wu, Fengying; Jiang, Yu; Lin, Yuechun; Wang, Lei; Zhou, Fei; Shen, Yue; Min, Zhen; Li, Wei; Liang, Wenhua; He, Jianxing; Zhou, Caicun Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 3, pp. -. DOI: 10.1016/j.jtho.2025.10.001 Neoadjuvant Immunochemotherapy in Resectable NSCLC With SMARCA4 Alterations Author: Peng, Li-Shan; Cui, Qian; Zhang, Chao; Lin, Jun-Tao; Wu, You; Kang, Jin; Xu, Zi-Yi; Wang, Xiang-Yang; Cao, Ying-Jiao; Zhang, Qing-Ling; Wu, Yi-Long; Hu, Zheng; Zhong, Wen-Zhao Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 3, pp. -. DOI: 10.1016/j.jtho.2025.10.013 Andamertinib in Advanced NSCLC With EGFR Exon 20 Insertions After Platinum-Based Chemotherapy or Immunotherapy: Results From the Phase 2 KANNON Study Author: Yang, Jin-Ji; Mu, Yu; Wang, Zhe-Hai; Duan, Jian-Chun; Zhang, Yan; Wu, Lin; Zhong, Hua; Zhao, Jun; Yao, Yu; Wang, Ping; Li, Xiao-Ling; Yang, Run-Xiang; Min, Xu-Hong; Lv, Dong-Qing; Xu, Hai-Peng; Fu, Zhen-Ming; Shen, Bo; Sun, Long-Hua; Wang, Chang-Li; Zhou, Jian-Ya; Xu, Rui-Lian; Ma, Hui-Wen; Zhao, Yan-Qiu; Shi, He-Peng; Zhang, Pei-Long; Xue, Wei-Zhe; Han, Di; Zheng, Yi; Wu, Yi-Long Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 3, pp. -. DOI: 10.1016/j.jtho.2025.11.008 Radiotherapy for Unresectable Locally Advanced NSCLC: A Practical Multidisciplinary Approach to Challenging Scenarios From the International Association for the Study of Lung Cancer Advanced Radiation Technology Subcommittee Author: Zhu, Hongcheng; Al Saifi, Said; Bahig, Houda; Cooper, Alissa; Abrao, Fernando Conrado; Corrales, Luis; Faivre-Finn, Corinne; Filippi, Andrea Riccardo; Fitzgerald, Bailey; Khosla, Divya; Lam, Vincent K.; Le, Xiuning; Menezes, Vanessa; Newsom-Davis, Tom; Qin, Angel; Putora, Paul Martin; Munoz-Schuffenegger, Pablo; Siva, Shankar; Yu, Nathan Y.; Louie, Alexander, V Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 3, pp. -. DOI: 10.1016/j.jtho.2025.11.006 | |||||||||||||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Journal of Thoracic Oncology的语言要求，还能让Journal of Thoracic Oncology编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Journal of Thoracic Oncology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||||||||||||
| 通讯方式 | LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA, 19106-3621 | |||||||||||||||||||||||||||||||
| 出版商 | International Association for the Study of Lung Cancer | |||||||||||||||||||||||||||||||
| 涉及的研究方向 | 医学-呼吸系统 | |||||||||||||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||||||||||||||||
| 出版年份 | 2006 | |||||||||||||||||||||||||||||||
| 年文章数 | 100点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||
| Gold OA文章占比 | 22.07% | |||||||||||||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 92.00% | |||||||||||||||||||||||||||||||
| WOS期刊JCR分区 （ 2024-2025年最新版） | WOS分区等级：1区
| |||||||||||||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||||||||||||
  | ||||||||||||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1556-0864%5BISSN%5D | |||||||||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 一般,3-6周 | |||||||||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 较易 | |||||||||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Journal of Thoracic Oncology顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | GSTA1 Conferred Tolerance to Osimertinib and Provided Strategies to Overcome Drug-Tolerant Persister in EGFR-Mutant Lung Adenocarcinoma Author: Zhang, Xiaoshen; Wen, Yaokai; Wu, Fengying; Jiang, Yu; Lin, Yuechun; Wang, Lei; Zhou, Fei; Shen, Yue; Min, Zhen; Li, Wei; Liang, Wenhua; He, Jianxing; Zhou, Caicun Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 3, pp. -. DOI: 10.1016/j.jtho.2025.10.001 PubMed DOI |
| 2. | Neoadjuvant Immunochemotherapy in Resectable NSCLC With SMARCA4 Alterations Author: Peng, Li-Shan; Cui, Qian; Zhang, Chao; Lin, Jun-Tao; Wu, You; Kang, Jin; Xu, Zi-Yi; Wang, Xiang-Yang; Cao, Ying-Jiao; Zhang, Qing-Ling; Wu, Yi-Long; Hu, Zheng; Zhong, Wen-Zhao Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 3, pp. -. DOI: 10.1016/j.jtho.2025.10.013 PubMed DOI |
| 3. | Andamertinib in Advanced NSCLC With EGFR Exon 20 Insertions After Platinum-Based Chemotherapy or Immunotherapy: Results From the Phase 2 KANNON Study Author: Yang, Jin-Ji; Mu, Yu; Wang, Zhe-Hai; Duan, Jian-Chun; Zhang, Yan; Wu, Lin; Zhong, Hua; Zhao, Jun; Yao, Yu; Wang, Ping; Li, Xiao-Ling; Yang, Run-Xiang; Min, Xu-Hong; Lv, Dong-Qing; Xu, Hai-Peng; Fu, Zhen-Ming; Shen, Bo; Sun, Long-Hua; Wang, Chang-Li; Zhou, Jian-Ya; Xu, Rui-Lian; Ma, Hui-Wen; Zhao, Yan-Qiu; Shi, He-Peng; Zhang, Pei-Long; Xue, Wei-Zhe; Han, Di; Zheng, Yi; Wu, Yi-Long Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 3, pp. -. DOI: 10.1016/j.jtho.2025.11.008 PubMed DOI |
| 4. | Radiotherapy for Unresectable Locally Advanced NSCLC: A Practical Multidisciplinary Approach to Challenging Scenarios From the International Association for the Study of Lung Cancer Advanced Radiation Technology Subcommittee Author: Zhu, Hongcheng; Al Saifi, Said; Bahig, Houda; Cooper, Alissa; Abrao, Fernando Conrado; Corrales, Luis; Faivre-Finn, Corinne; Filippi, Andrea Riccardo; Fitzgerald, Bailey; Khosla, Divya; Lam, Vincent K.; Le, Xiuning; Menezes, Vanessa; Newsom-Davis, Tom; Qin, Angel; Putora, Paul Martin; Munoz-Schuffenegger, Pablo; Siva, Shankar; Yu, Nathan Y.; Louie, Alexander, V Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 3, pp. -. DOI: 10.1016/j.jtho.2025.11.006 PubMed DOI |
| 5. | Response to Letter to the Editor: Refining Immunochemoradiotherapy for Patients With NSCLC and Brain Metastases: Insights on Biomarkers, Neuroprotection, and Global Applicability Author: Li, Yang-Si; Yang, Jin-Ji; Wu, Yi-Long Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 2, pp. 335-336. DOI: 10.1016/j.jtho.2025.08.023 PubMed DOI |
| 6. | A Game-Changing 20 Years: Progress and Future Directions in Lung Cancer Screening Author: Lam, Stephen; Baldwin, David R.; Devaraj, Anand; Field, John; Henschke, Claudia I.; Heuvelmans, Marjolein A.; Huber, Rudolf M.; Jones, Catherine; Borondy-Kitts, Andrea; Li, Molly Siu Ching; Myers, Renelle; Osarogiagbon, Raymond U.; Robbins, Hilary A.; Tammemagi, Martin C.; Taylor, Kathryn L.; Triphuridet, Natthaya; Williams, Randi M.; Yankelevitz, David Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 2, pp. 235-252. DOI: 10.1016/j.jtho.2025.11.017 PubMed DOI |
| 7. | A Grading System for Resected Invasive Squamous Cell Carcinoma of the Lung: A Multi-Institutional Study by the IASLC Pathology Committee Author: Mino-Kenudson, Mari; Berezowska, Sabina; Minami, Yuko; Chen, Shuyan; Ray, Meredith A.; Rerkpichaisuth, Vilasinee; Hashisako, Mikiko; Losmanova, Tereza; Hayashi, Takuo; Shim, Hyo-Sup; Righi, Luisella; Gagne, Andreanne; Kim, Tae-Jung; Bubendorf, Lukas; Lopez-Rios, Fernando; Matsubara, Daiske; Von Der Thusen, Jan; Lantuejoul, Sylvie; Roden, Anja C.; Nicholson, Andrew; Jain, Deepali; Han, Yuchen; Wynes, Murry W.; Dacic, Sanja; Smeltzer, Mathew P.; Cooper, Wendy A.; Papotti, Mauro G Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 2, pp. 294-309. DOI: 10.1016/j.jtho.2025.09.1761 PubMed DOI |
| 8. | The International Association for the Study of Lung Cancer Staging Project: The Impact of Common Molecular Alterations on Overall Survival in NSCLC in Initial Analyses of the IASLC Ninth Edition Staging Database (vol 20, pg 1423, 2025) Author: Carbone, David P.; Hirsch, Fred R.; Osarogiagbon, Raymond Uyiosa; Nishimura, Katherine K.; Tsao, Ming Sound; Travis, William D.; Yang, Dawei; Yang, Soo-Ryum; Yatabe, Yasushi; Araujo, Luiz Henrique; Detterbeck, Frank; Lechtenberg, Kendra J.; Lim, Eric; Mack, Philip C.; Matilla, Jose-Maria; Montuenga, Luis M.; Nicholson, Andrew G.; Suda, Kenichi; Terra, Ricardo M.; Rami-Porta, Ramon; Asamura, Hisao; Rusch, Valerie; Wynes, Murry W Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 2, pp. 342-342. DOI: PubMed |
| 9. | Fine Particulate Matter (PM2.5) as a Driver of Genomic Alterations and Lung Tumour Initiation Author: Wang, P.; Naso, J.; Myers, R.; Durney, C. H.; Bartolomeu, C.; Mcguire, A.; Macaulay, C.; Lam, S.; Lam, W. L.; Lockwood, W. W Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 1, pp. -. DOI: |
| 10. | Myeloid IL-1 Signaling Drives The Precancer-to-Cancer Evolution of Human Pulmonary Nodules Author: Park, Matthew D.; Hu, Xin; Montegut, Lea; Zhu, Bo; Vokes, Natalie; Fujimoto, Junya; Hong, Lingzhi; Heeke, Simon; Moreira, Andre L.; Solis, Luisa M.; Haymaker, Cara; Velcheti, Vamsidhar; Sterman, Daniel H.; Pass, Harvey I.; Cheng, Chao; Lee, Jack J.; Wei, Zhu-Bo; Wu, Jia; Su, Dan; Wang, Ling-Hua; Davis, Mark M.; Heymach, John V.; Wistuba, Ignacio; Dubinett, Steven; Lippman, Scott; Spira, Avrum; Samstein, Robert M.; Mantovani, Alberto; Futreal, Andrew P.; Reuben, Alexandre; Merad, Miriam; Zhang, Jianjun Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 1, pp. -. DOI: |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共46条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
